Find your next M&A target

Target Asia + Worldwide M&A projects with our guidance on matching, planning, due diligence & implementation.

Project details

Cambridge based biotech R&D firm with unparalleled track record looking for investors

Project region Britain
Industry Healthcare
Total value of the target N/A
Expected target net rate of return after deducting all taxes and fees N/A
Validity period of pending order 365


  • Simon Laube

    Simon Laube

    Assistant Manager, International Business Advisory

Project highlights To be confirmed
Project description

The company is a Cambridge based biotechnology contract research and drug development company, which operates a mixed business model. The revenue is generated through its service business and the development of drug products. The company has an excellent track record in candidate drug delivery. It has a world-class discovery team, and its unparalleled track record shows that it has delivered one candidate drug on behalf of its customers every year in the past six years. Revenue in 2019 was approximately £ 6 million, of which 83% of sales came from a strong growing industrial customer base, which has now become the core of the business.

Enquire for more information about our services, and how we can help solve challenges for your organization

Contact Us
The code is case-sensitive